215 related articles for article (PubMed ID: 12102182)
1. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials.
Radin S; Falaize S; Lee MH; Ducheyne P
Biomaterials; 2002 Aug; 23(15):3113-22. PubMed ID: 12102182
[TBL] [Abstract][Full Text] [Related]
2. In vivo tissue response to resorbable silica xerogels as controlled-release materials.
Radin S; El-Bassyouni G; Vresilovic EJ; Schepers E; Ducheyne P
Biomaterials; 2005 Mar; 26(9):1043-52. PubMed ID: 15369693
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcium salt content in the poly(epsilon-caprolactone)/silica nanocomposite on the nucleation and growth behavior of apatite layer.
Rhee SH
J Biomed Mater Res A; 2003 Dec; 67(4):1131-8. PubMed ID: 14624498
[TBL] [Abstract][Full Text] [Related]
4. Enhanced apatite-forming ability and antibacterial activity of porous anodic alumina embedded with CaO-SiO2-Ag2O bioactive materials.
Ni S; Li X; Yang P; Ni S; Hong F; Webster TJ
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():700-8. PubMed ID: 26478362
[TBL] [Abstract][Full Text] [Related]
5. In vitro apatite forming ability of type I collagen hydrogels containing bioactive glass and silica sol-gel particles.
Eglin D; Maalheem S; Livage J; Coradin T
J Mater Sci Mater Med; 2006 Feb; 17(2):161-7. PubMed ID: 16502249
[TBL] [Abstract][Full Text] [Related]
6. Petal-like apatite formed on the surface of tricalcium phosphate ceramic after soaking in distilled water.
Lin FH; Liao CJ; Chen KS; Su JS; Lin CP
Biomaterials; 2001 Nov; 22(22):2981-92. PubMed ID: 11575472
[TBL] [Abstract][Full Text] [Related]
7. Effect of Washing Treatment on the Textural Properties and Bioactivity of Silica/Chitosan/TCP Xerogels for Bone Regeneration.
Pérez-Moreno A; Reyes-Peces MV; Vilches-Pérez JI; Fernández-Montesinos R; Pinaglia-Tobaruela G; Salido M; de la Rosa-Fox N; Piñero M
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361087
[TBL] [Abstract][Full Text] [Related]
8. In vitro release of cisplatin from sol-gel processed organically modified silica xerogels.
Czarnobaj K; Lukasiak J
J Mater Sci Mater Med; 2007 Oct; 18(10):2041-4. PubMed ID: 17558477
[TBL] [Abstract][Full Text] [Related]
9. A bioactive coating of a silica xerogel/chitosan hybrid on titanium by a room temperature sol-gel process.
Jun SH; Lee EJ; Yook SW; Kim HE; Kim HW; Koh YH
Acta Biomater; 2010 Jan; 6(1):302-7. PubMed ID: 19531388
[TBL] [Abstract][Full Text] [Related]
10. Molybdenum effect on the structure of SiO₂-CaO-P₂O₅ bioactive xerogels and on their interface processes with simulated biofluids.
Ponta O; Ciceo-Lucacel R; Vulpoi A; Radu T; Simon S
J Biomed Mater Res A; 2014 Sep; 102(9):3177-85. PubMed ID: 24142573
[TBL] [Abstract][Full Text] [Related]
11. Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica/collagen xerogels.
Kruppke B; Hose D; Schnettler R; Seckinger A; Rößler S; Hanke T; Heinemann S
J Biomed Mater Res B Appl Biomater; 2018 Apr; 106(3):1165-1173. PubMed ID: 28556562
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro evaluation of porous silica gels.
Gallardo J; Galliano PG; Porto López JM
Biomaterials; 2002 Nov; 23(21):4277-84. PubMed ID: 12194530
[TBL] [Abstract][Full Text] [Related]
13. Calcium phosphate phases integrated in silica/collagen nanocomposite xerogels enhance the bioactivity and ultimately manipulate the osteoblast/osteoclast ratio in a human co-culture model.
Heinemann S; Heinemann C; Wenisch S; Alt V; Worch H; Hanke T
Acta Biomater; 2013 Jan; 9(1):4878-88. PubMed ID: 23072829
[TBL] [Abstract][Full Text] [Related]
14. Silica xerogels as pharmaceutical drug carriers.
Quintanar-Guerrero D; Ganem-Quintanar A; Nava-Arzaluz MG; Piñón-Segundo E
Expert Opin Drug Deliv; 2009 May; 6(5):485-98. PubMed ID: 19413456
[TBL] [Abstract][Full Text] [Related]
15. Fluoride-containing nanoporous calcium-silicate MTA cements for endodontics and oral surgery: early fluorapatite formation in a phosphate-containing solution.
Gandolfi MG; Taddei P; Siboni F; Modena E; Ginebra MP; Prati C
Int Endod J; 2011 Oct; 44(10):938-49. PubMed ID: 21726240
[TBL] [Abstract][Full Text] [Related]
16. Bioactive silica-based nanomaterials for doxorubicin delivery: evaluation of structural properties associated with release rate.
Prokopowicz M
Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3942-50. PubMed ID: 23910300
[TBL] [Abstract][Full Text] [Related]
17. Apatite-forming ability and mechanical properties of PTMO-modified CaO-SiO2 hybrids prepared by sol-gel processing: effect of CaO and PTMO contents.
Miyata N; Fuke K; Chen Q; Kawashita M; Kokubo T; Nakamura T
Biomaterials; 2002 Jul; 23(14):3033-40. PubMed ID: 12069346
[TBL] [Abstract][Full Text] [Related]
18. The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds.
Morpurgo M; Teoli D; Pignatto M; Attrezzi M; Spadaro F; Realdon N
Acta Biomater; 2010 Jun; 6(6):2246-53. PubMed ID: 20035908
[TBL] [Abstract][Full Text] [Related]
19. The effect of PEG concentration on the release rate of cisplatin from PEG-modified silica xerogels.
Czarnobaj K; Prokopowicz M; Lukasiak J
Drug Deliv; 2006; 13(5):339-44. PubMed ID: 16877308
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of silica xerogels as carriers for drugs.
Czarnobaj K
Drug Deliv; 2008 Nov; 15(8):485-92. PubMed ID: 18798086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
